Dongguan, China

Qibiao Huang

This inventor holds 1 USPTO granted patent. Top assignee: North & South Brother Pharmacy Investment Company Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qibiao Huang. Retrieved from https://idiyas.com/inventor/qibiao-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qibiao Huang: Innovator in Pharmaceutical Composition

Introduction

Qibiao Huang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid compositions for medications. His innovative work has led to the creation of a patent that addresses important aspects of drug formulation.

Latest Patents

Qibiao Huang holds a patent for an "Apixaban solid composition and preparation method thereof." This invention provides a method for granulating apixaban through wet granulation, ensuring that the particle size of the apixaban is greater than 89 micrometers. This advancement is crucial for improving the efficacy and stability of the medication.

Career Highlights

Qibiao Huang is associated with North & South Brother Pharmacy Investment Company Limited, where he applies his expertise in pharmaceutical development. His work focuses on enhancing drug formulations to better serve patients and healthcare providers.

Collaborations

Some of his coworkers include Xin Huang and Fangfang Huang, who contribute to the collaborative efforts within the company. Their teamwork fosters an environment of innovation and progress in pharmaceutical research.

Conclusion

Qibiao Huang's contributions to the pharmaceutical industry through his patent and collaborative work highlight his role as an important inventor. His dedication to improving drug formulations continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…